Company Data

Eliem Therapeutics Inc

Ticker
ELYM
Price Target
Refer to Report
Volume
1.6M
52wk Range
$2.35 - $11.55
Advanced Market Data

Overview

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy